Predictions of Programmed Cell Death Ligand 1 Blockade Therapy Success in Patients with Non-Small-Cell Lung Cancer

Predictions of Programmed Cell Death Ligand 1 Blockade Therapy Success in Patients with Non-Small-Cell Lung Cancer

Lung cancer is responsible for the most cancer deaths worldwide, with non-small-cell lung cancer (NSCLC) making up 80% of cases. Some genetic factors leading to NSCLC development include genetic mutations and Programmed Cell Death Ligand 1 (PD-L1) expression. PD-L1 proteins are targeted in an NSCLC...

Full description

Bibliographic Details
Main Authors: Taksh Gupta, Tamara Qawasmeh, Serena McCalla
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:BioMedInformatics
Subjects:
non-small-cell lung cancer
PD-L1 blockade therapy
immune therapy
immune checkpoint inhibitors
PD-L1 proteins
Gaussian naïve Bayes
Online Access:https://www.mdpi.com/2673-7426/3/4/63

Internet

https://www.mdpi.com/2673-7426/3/4/63

Similar Items